Skip to Content
Severe eczema holding you back? Find the right treatment

Imiquimod topical Pregnancy and Breastfeeding Warnings

Imiquimod topical is also known as: Aldara, Zyclara

Imiquimod topical Pregnancy Warnings

Imiquimod topical has been assigned to pregnancy category C by the FDA. Animal studies have revealed fetal toxicities, in the presence of maternal toxicity, including fetal resorptions, decreased fetal body weights, delays in skeletal ossification, and bent limb bones following doses 163 to 577 times the MHRD (based on AUC comparisons). In this same dosage group two fetuses in one litter demonstrated exencephaly, protruding tongues, and low set ears. Animal studies have failed to reveal evidence of teratogenicity or embryofetal toxicity when administered in doses up to 28 to 98 times MHRD (based on AUC comparisons). There are no controlled data in human pregnancy. Imiquimod topical is only recommended for use during pregnancy when benefit outweighs risk.

See references

Imiquimod topical Breastfeeding Warnings

There are no data on the excretion of imiquimod into human milk. The manufacturer recommends that caution be used when administering imiquimod to nursing women.

See references

References for pregnancy information

  1. "Product Information. Aldara (imiquimod topical)." 3M Pharmaceuticals, St. Paul, MN.

References for breastfeeding information

  1. "Product Information. Aldara (imiquimod topical)." 3M Pharmaceuticals, St. Paul, MN.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.